Your browser is no longer supported. Please, upgrade your browser.
ALLK Allakos Inc. daily Stock Chart
ALLK [NASD]
Allakos Inc.
Index- P/E- EPS (ttm)-1.70 Insider Own0.70% Shs Outstand51.28M Perf Week-7.06%
Market Cap3.27B Forward P/E- EPS next Y-2.72 Insider Trans0.00% Shs Float43.34M Perf Month-22.69%
Income-75.30M PEG- EPS next Q-0.47 Inst Own81.00% Short Float17.86% Perf Quarter-16.58%
Sales- P/S- EPS this Y-73.60% Inst Trans-3.31% Short Ratio17.09 Perf Half Y-27.43%
Book/sh11.12 P/B5.74 EPS next Y-47.00% ROA-27.90% Target Price113.00 Perf Year75.83%
Cash/sh10.08 P/C6.33 EPS next 5Y- ROE-29.60% 52W Range30.32 - 139.99 Perf YTD-33.03%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-53.25% Beta-
Dividend %- Quick Ratio41.60 Sales past 5Y- Gross Margin- 52W Low115.83% ATR3.82
Employees77 Current Ratio41.60 Sales Q/Q- Oper. Margin- RSI (14)31.10 Volatility5.52% 5.87%
OptionableYes Debt/Eq0.00 EPS Q/Q-77.40% Profit Margin- Rel Volume0.59 Prev Close63.86
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume452.98K Price65.44
Recom1.70 SMA20-7.77% SMA50-26.24% SMA200-7.05% Volume170,645 Change2.47%
Feb-04-20Resumed Goldman Neutral $89 → $94
Aug-13-18Initiated William Blair Outperform
Aug-13-18Initiated Jefferies Buy $53
Aug-13-18Initiated Goldman Neutral $31
Feb-19-20 07:30PM  ROSEN, NATIONAL TRIAL LAWYERS, Continues to Investigate Securities Claims Against Allakos Inc. ALLK GlobeNewswire
11:50AM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Feb-18-20 08:05PM  ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Feb-17-20 10:10AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation Allakos Inc. (ALLK) ACCESSWIRE
Feb-15-20 12:00PM  ROSEN, A LEADING INVESTOR FIRM, Continues to Investigate Securities Claims Against Allakos Inc. ALLK Business Wire
Feb-13-20 08:15PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Feb-11-20 02:09PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK GlobeNewswire
Feb-05-20 11:55PM  ALLK LOSSES ALERT: Bernstein Liebhard Encourages Investors with Losses in Allakos Inc., to Contact the Firm and Reminds Investors of its Investigation of the Company ACCESSWIRE
04:45PM  ALLK ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Allakos Inc. ALLK GlobeNewswire
Feb-03-20 03:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc.  ALLK GlobeNewswire
01:54PM  ALLK LOSSES ALERT: Bernstein Liebhard Encourages Investors with Losses in Allakos Inc., to Contact the Firm and Reminds Investors of its Investigation of the Company ACCESSWIRE
Jan-31-20 05:20PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE -6.28%
Jan-29-20 04:40PM  ALLK LOSSES ALERT: Bernstein Liebhard Reminds Investors of its Investigation of Allakos Inc. ACCESSWIRE
02:21PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK GlobeNewswire
Jan-28-20 09:40PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE +5.23%
Jan-27-20 03:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE +5.31%
Jan-23-20 06:45PM  ROSEN, A TOP RANKED LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc. ALLK GlobeNewswire -9.17%
Jan-22-20 03:45PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Jan-20-20 09:21AM  Companies Like Allakos (NASDAQ:ALLK) Can Afford To Invest In Growth Simply Wall St.
12:05AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Jan-17-20 07:44PM  ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc. - ALLK PR Newswire
02:15PM  SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Jan-16-20 07:40PM  ALLK Investor Alert: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm ALLK GlobeNewswire
01:50PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:02AM  Block & Leviton LLP Alerts Investors of Investigations into Allakos and Sterling Bancorp for Violations of Federal Securities Laws GlobeNewswire
Jan-14-20 06:26PM  ALLK LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of its Investigation of Allakos Inc. ACCESSWIRE
01:12PM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
Jan-09-20 12:09PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
11:29AM  ALLK LOSS NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Announces Investigation of Securities Claims Against Allakos Inc. ALLK Business Wire
09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK GlobeNewswire
Jan-06-20 06:35PM  ALLK LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of its Investigation of Allakos Inc. ACCESSWIRE
09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK PR Newswire
Jan-03-20 07:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK GlobeNewswire
04:00PM  Glancy Prongay & Murray LLP Continues Its Investigation on Behalf of Allakos Inc. Investors Business Wire
01:32PM  INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Allakos Inc. Investors Business Wire
Dec-23-19 08:05AM  Two Biotech Plays to Consider From the Long Side TheStreet.com -5.79%
Dec-21-19 07:06AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE
Dec-19-19 09:44PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Significant Losses to Contact Its Attorneys; Firm Investigating Possible Securities Fraud PR Newswire -7.95%
08:02PM  ALLAKOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Allakos, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm Business Wire
04:00PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Allakos Inc. Investors Business Wire
03:04PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Allakos Inc. Investors Business Wire
01:41PM  ALLK LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of its Investigation of Allakos Inc. PR Newswire
11:32AM  Allakos, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire
10:55AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Allakos Inc. (ALLK) ACCESSWIRE
09:27AM  ALLK LOSSES ALERT: Bernstein Liebhard LLP Announces an Investigation of Allakos Inc. ACCESSWIRE
Dec-18-19 06:50PM  ALLK LOSSES ALERT: Bernstein Liebhard LLP Announces an Investigation of Allakos Inc. Business Wire -10.00%
05:28PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK GlobeNewswire
Dec-11-19 02:19PM  Hedge Funds Have Never Been This Bullish On Allakos Inc. (ALLK) Insider Monkey
Dec-05-19 07:14AM  The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission Benzinga -10.65%
Dec-04-19 05:18PM  U.S. biotech firm Allakos exploring options, including sale - Bloomberg Reuters +43.56%
03:24PM  Allakos stock jumps in afternoon trading MarketWatch
Nov-12-19 04:01PM  Allakos Reports Third Quarter 2019 Financial Results GlobeNewswire
Oct-28-19 09:01AM  Allakos Announces Multiple Presentations from Its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting GlobeNewswire
Oct-27-19 10:48AM  Allakos Inc. (ALLK): These Hedge Funds Regret Cashing Out Too Early Insider Monkey
Oct-18-19 10:23AM  These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals
Sep-17-19 04:22PM  Zscaler stock jumps on news of partnership with CrowdStrike American City Business Journals
Sep-07-19 03:00PM  Why Allakos Stock Skyrocketed 154% in August Motley Fool
Aug-13-19 05:20AM  Will Allakos Continue to Surge Higher? Zacks
Aug-09-19 10:09AM  Top Ranked Momentum Stocks to Buy for August 9th Zacks
Aug-07-19 12:11PM  A Look At Benzinga Pro's Most-Searched Tickers For August 7, 2019 Benzinga +10.10%
Aug-06-19 10:18PM  Allakos Announces Upsizing and Pricing of Public Offering of Common Stock GlobeNewswire +21.77%
Aug-05-19 04:29PM  Allakos Announces Proposed Public Offering of Common Stock GlobeNewswire +110.52%
12:21PM  A Look At Benzinga Pro's Most-Searched Tickers For August 5, 2019 Benzinga
10:34AM  Pharma Stock Set to Double Today Schaeffer's Investment Research
10:34AM  Small Biotech Doubles as Drug Shows Promise in Rare Diseases Bloomberg
07:15AM  Allakos Reports Second Quarter 2019 Financial Results GlobeNewswire
07:09AM  Allakos Stock Doubles on Positive Stomach Disease Drug Study Data TheStreet.com
07:00AM  Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE) GlobeNewswire
Jul-24-19 01:40PM  Imagine Owning Allakos (NASDAQ:ALLK) And Wondering If The 17% Share Price Slide Is Justified Simply Wall St.
Jun-19-19 07:10AM  Ohio Capital Fund's management firm seeks 3-year extension, raise American City Business Journals
May-08-19 08:01AM  Allakos Reports First Quarter 2019 Financial Results GlobeNewswire
May-07-19 04:01PM  Allakos Announces Positive Results with AK002 in Patients with Severe Allergic Conjunctivitis GlobeNewswire
May-01-19 12:17PM  Is Allakos Inc. (ALLK) A Good Stock To Buy? Insider Monkey
Mar-14-19 04:01PM  Allakos Reports Fourth Quarter and Full Year 2018 Financial Results and 2018 Corporate Highlights GlobeNewswire
Mar-11-19 11:54AM  State-backed VC vehicle managers aren't worried about dipping into tax credits here's why American City Business Journals +6.57%
Feb-19-19 08:00AM  Allakos Announces Positive Phase 1 Results with AK002 in Indolent Systemic Mastocytosis GlobeNewswire
Feb-14-19 06:11AM  Allakos Enters Oversold Territory Zacks
Feb-11-19 08:00AM  Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts GlobeNewswire -10.46%
Feb-04-19 08:00AM  Allakos to Host Investor Day on February 19 in New York City GlobeNewswire
Jan-29-19 08:00AM  Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism GlobeNewswire -7.70%
Jan-07-19 08:00AM  Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-Naïve Chronic Spontaneous Urticaria Patients GlobeNewswire -7.85%
Jan-02-19 01:15PM  Here are the winners and losers from Bay Area's IPO class of 2018 American City Business Journals
Dec-27-18 08:14AM  5 Best-Performing IPOs of 2018 Zacks
Dec-21-18 07:24PM  Assessing the Performance of 2018s Major IPOs Barrons.com
08:49AM  Allakos (ALLK) Catches Eye: Stock Jumps 6.5% Zacks
Nov-26-18 02:03PM  Here's how much better insiders have profited from this year's IPO boom American City Business Journals
Nov-22-18 12:19PM  Has Allakos Inc (NASDAQ:ALLK) Got Enough Cash? Simply Wall St.
Nov-21-18 07:30AM  New Research Coverage Highlights TheStreet, EVO Payments, Odyssey Marine Exploration, Allakos, SORL Auto Parts, and SPAR Group Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-08-18 04:01PM  Allakos Announces Clinical Update and Third Quarter 2018 Financial Results GlobeNewswire
Oct-08-18 08:00AM  Allakos Presents Data from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting GlobeNewswire
Aug-29-18 04:01PM  Allakos Announces Second Quarter 2018 Financial Results GlobeNewswire
Aug-13-18 02:52PM  Mixed Reviews For Allakos As Sell-Side Starts Coverage Of Biotech Benzinga
Jul-24-18 08:00AM  Allakos Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire +5.04%
Jul-19-18 01:50PM  Biotech Allakos shares surge more than 70% in trading debut MarketWatch
11:31AM  [$$] Health-Care Companies Keep Up Rapid Pace of IPOs The Wall Street Journal
07:50AM  Biotech Allakos prices IPO at $18, above price range MarketWatch
07:00AM  Allakos Announces Pricing of Initial Public Offering GlobeNewswire
Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.